Skip to main content
. 2019 Jun 20;8:908. [Version 1] doi: 10.12688/f1000research.19592.1

Figure 2. Visualizing drug-target interaction evidence for FDA-approved drug sorafenib via a histogram of drug-target assay values categorized by assay types (KD, EC50, IC50, and Ki).

Figure 2.

Sorafenib interacts with many targets, even when restricting to target interactions supported by binding assay evidence < 100 nM.